Efficacy of EUSOL, Neem, and TCDO in Full-Thickness Wound Healing: Histological and Hematological Assessment in Rabbits
Keywords:
Eusol, Corpuscular hemoglobin, Mean corpuscular volume, Neem, Tetrachlorodecaoxide, WoundAbstract
Treatment of wound focuses on Promoting, Preventing infection, rapid healing, minimizing Pain and adverse consequences. Conventional treatment is associated high cost which in most of the cases remains beyond the capacity of poor people. Current trial designed to evaluate the comparative healing efficiency of Tetrachlorodecaoxide (TCDO), Neem and Eusol solution against full thickness wounds. Fifty male rabbits aged 8–10 weeks, weighing 1500 ± 20 g, were randomly divided into five groups (G1–G5), with ten rabbits each. The animals were housed under controlled conditions (25 ± 2°C, 40–60% humidity, 12-hour light/dark cycle) in individual metal cages. Two full-thickness wounds (2 cm × 2 cm each) were created on either side of the rabbits using a No. 11 scalpel blade and scissors. Group G1 served as the negative control (placebo treatment), while G2 was the positive control (normal saline). Groups G3, G4, and G5 were treated with Tetrachlorodecaoxide (TCDO), Neem oil, and Eusol, respectively, applied twice daily. Wound healing was evaluated based on contraction rate and hematological parameters (assessed on days 0, 7, 14, 21, and 28). Histopathological analysis was conducted post-biopsy at the study's conclusion. Statistical analysis revealed that TCDO (G3) promoted faster wound healing by day 14 compared to Neem oil (G4) and Eusol (G5), which showed similar results by day 21. The positive control (G2) exhibited slower healing. Hematological parameters—including RBC count, MCV, MCH, platelets, and WBCs—differed significantly (p < 0.05) in TCDO, Neem oil, and Eusol groups compared to G2 on days 7–28. Notably, RBCs (p < 0.01), MCV (p < 0.001), MCH (p < 0.001), platelets (p < 0.001), and WBCs (p < 0.001) showed highly significant improvements in all treatment groups versus G2. Histopathological examination indicated superior epithelialization, fibrosis, and angiogenesis in TCDO and Eusol groups, confirming their enhanced wound-healing efficacy. In conclusion, Tetrachlorodecaoxide (TCDO) application showed more rapid recovery as compared to EUSOL and Neem oil.
References
. Upadhyay, N.K., R. Kumar, M. Siddiqui and A. Gupta. 2011. Mechanism of wound-healing activity ofHippophae rhamnoides L. leaf extract in experimental burns. Evid. Based Complement.Alternat. Med. 2011.
. Gosain, A., & DiPietro, L. A. (2004). Aging and wound healing. World J. Surg. 28:321-326. 2.
. Menke, N. B., Ward, K. R., Witten, T. M., Bonchev, D. G., & Diegelmann, R. F. (2007). Impaired wound healing. Clinics in dermatology, 25: 19-25.
. Senthil Kumar M, Sripriya R, Vijaya Raghavan H and Sehgal P (2006). Wound Healing Potential of Cassia fistula on Infected Albino Rat Model. J. Surg. Res. 131: 283-289.
. Guo, S. A., & DiPietro, L. A. (2010). Factors affecting wound healing. Journal of dental research, 89(3), 219-229.
. Hinz, J., H. Hautzinger and K.-W. Stahl. 1986. Rationale for and results from a randomised, double-blind trial of tetrachlorodecaoxygen anion complex in wound healing. The Lancet. 327:825-828.
. Youngman, R., G. Wagner, F. Kühne and E. Elstner. 1985. Biochemical oxygen activation as the basis for the physiological action of tetrachlorodecaoxide (TCDO). Zeitschrift für Naturforschung C. 40:409-414.
. Ullmann, U. and F. Kühne. 1985. In vitro investigations on the antibacterial action and the influence on the phagocytic chemiluminescence of tetrachlorodecaoxidea new, non-metallic oxygen complex. Infection. 13:S236-S240.
. Bajaj, G., N. Karn, B. Shrestha, P. Kumar and M. Singh. 2009. A randomised controlled trial comparing eusol and sugar as dressing agents in the treatment of traumatic wounds. Tropical doctor. 39:1-3.
. Catlin, L. 1992. The use of hypochlorite solutions in wound management. Br. J. Nurs.. 1:226-229.
. Sue Bale.(1985).EUSOL revisited. 7th edition of the dressing times.
. Kaur, G., M. Sarwar Alam and M. Athar. 2004. Nimbidin suppresses functions of macrophages and neutrophils: relevance to its antiinflammatory mechanisms. Phytotherapy Research: AIJPTR. Evaluation of Natural Product Derivatives. 18:419-424.
. Ghimeray, A. K., Jin, C. W., Ghimire, B. K., & Cho, D. H. (2009). Antioxidant activity and quantitative estimation of azadirachtin and nimbin in Azadirachta indica A. Juss grown in foothills of Nepal. African Journal of Biotechnology, 8(13).
. Henke, J., S. Astner, T. Brill, B. Eissner, R. Busch and W. Erhardt. 2005. Comparative study
of three intramuscular anaesthetic combinations (medetomidine/ketamine,
medetomidine/fentanyl/midazolam and xylazine/ketamine) in rabbits. Vet Anaesth
Analg. 32: 261-270.
. Zenker W, Thiede A, Dommes M. et al. Effectiveness of tetrachlorodecaoxide (TCDO) in the treatment of complicated disorders of wound healing: a controlled study: TCDO versus PVP-iodine complex. Chirurg 1986; 57: 334-339
. Rashid, A., A. Ul Lateef, M.R. Gulzar, D. Muhammad and N.U. Rehman. 2014. Comparison between Role of Honey Dressing and Oxoferin (Tetrachlorodecaoxide) Dressing In the Management of Infected Wounds in Diabetic Amputated Limbs. Annals of Punjab Medical College (APMC). 8:73-77.
. Yingsakmongkol, N., Maraprygsavan, P., & Sukosit, P. (2011). Effect of WF10 (immunokine) on diabetic foot ulcer therapy: a double-blind, randomized, placebo-controlled trial. The Journal of foot and ankle surgery, 50(6), 635-640.
. Parikh, R., G. Bakhshi, M. Naik, B. Gaikwad, K. Jadhav and M. Tayade. 2016. The efficacy and safety of tetrachlorodecaoxide in comparison with super-oxidised solution in wound healing. Archives of plastic surgery. 43:395.